PD-1/L1 Inhibitors may Increase the Risk of Pericardial Disease in NSCLC Patients: A Meta-Analysis and Systematic Review. Supplementary materials

figure

posted on 2022-04-04, 09:53 authored by Xiurong Li, Lucheng Song, Feiran Yang, Huijie Liu, Xiaoteng Feng, Lei Zhang, Deting Han, Honglin Li

PD-1/L1 Inhibitors may Increase the Risk of Pericardial Disease in NSCLC Patients: A Meta-Analysis and Systematic Review